201046-59-5 Usage
Description
Fmoc-Orn(Fmoc)-OH, also known as Nα-(9-fluorenylmethoxycarbonyl)-Nε-(9-fluorenylmethoxycarbonyl)-L-ornithine, is a synthetic derivative used in the field of peptide chemistry. It is a white to off-white powder and is characterized by its unique chemical properties that make it suitable for the synthesis of branched peptides.
Uses
Used in Pharmaceutical Industry:
Fmoc-Orn(Fmoc)-OH is used as a building block for the synthesis of branched peptides, which are essential in the development of various pharmaceutical compounds. The compound's ability to form branched peptides allows for the creation of complex molecular structures with potential applications in drug design and development.
Used in Research and Development:
In the field of research and development, Fmoc-Orn(Fmoc)-OH is utilized as a key component in the synthesis of novel peptides with specific biological activities. Its use in this context aids scientists in understanding the structure-function relationships of peptides and their potential therapeutic applications.
Used in Chemical Synthesis:
Fmoc-Orn(Fmoc)-OH is also used as a reagent in chemical synthesis, particularly in the preparation of complex organic molecules. Its unique properties enable the formation of branched peptide structures, which can be further modified or functionalized to create a wide range of chemical compounds with various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 201046-59-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,1,0,4 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 201046-59:
(8*2)+(7*0)+(6*1)+(5*0)+(4*4)+(3*6)+(2*5)+(1*9)=75
75 % 10 = 5
So 201046-59-5 is a valid CAS Registry Number.
201046-59-5Relevant articles and documents
Amino acid derivatives as HIV aspartyl protease inhibitors
-
, (2008/06/13)
The present invention relates to a class of amino acid derivatives with HIV aspartyl protease inhibitory properties.